Viewing Study NCT06016920

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:18 AM
Ignite Modification Date: 2026-05-27 @ 6:55 PM
Study NCT ID: NCT06016920
Status: RECRUITING
Last Update Posted: 2024-12-17
First Post: 2023-08-24
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Efficacy of VB10.16 and Pembrolizumab in Patients with Head-Neck Squamous Cell Carcinoma
Sponsor: Nykode Therapeutics ASA
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HPV Positive Oropharyngeal Squamous Cell Carcinoma View
None HNSCC View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Unresectable View
None recurrent View
None metastatic View
None HPV16 positive View
None PD-L1 View